Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Hartley

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Journal of Leukocyte Biology|May 10, 2015
CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cellsJames M Fox, Richard Kasprowicz, Oliver Hartley, et al.
Journal of Leukocyte Biology|September 12, 2006
N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variantJean K Lim, Wuyuan Lu, Oliver Hartley, et al.
Bioconjugate Chemistry|January 9, 2008
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV proteinHubert Gaertner, Robin Offord, Paolo Botti, et al.
Brain Research. Brain Research Reviews|February 15, 2005
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseasesLaetitia Cartier, Oliver Hartley, Michel Dubois-Dauphin, et al.
The Journal of Biological Chemistry|October 12, 2018
Rapid and low-cost multiplex synthesis of chemokine analogsMarianne Paolini-Bertrand, Fabrice Cerini, Elsa Martins, et al.
The Journal of Biological Chemistry|November 3, 2010
CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi networkJean-Michel Escola, Gabriel Kuenzi, Hubert Gaertner, et al.
Plos One|April 30, 2015
Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5Claudia Bönsch, Mihaela Munteanu, Irène Rossitto-Borlat, et al.
AIDS Research and Human Retroviruses|February 24, 2005
V3: HIV's switch-hitterOliver Hartley, Per Johan Klasse, Quentin J Sattentau, et al.
Vaccine|May 16, 2008
Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccinationKarim Dorgham, Valérie Abadie, Mutsunori Iga, et al.
Molecular Pharmacology|September 18, 2020
Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment BiasElsa Martins, Hellena Brodier, Irène Rossitto-Borlat, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Journal of Leukocyte Biology|May 10, 2015
CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cellsJames M Fox, Richard Kasprowicz, Oliver Hartley, et al.
Journal of Leukocyte Biology|September 12, 2006
N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variantJean K Lim, Wuyuan Lu, Oliver Hartley, et al.
Bioconjugate Chemistry|January 9, 2008
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV proteinHubert Gaertner, Robin Offord, Paolo Botti, et al.
Brain Research. Brain Research Reviews|February 15, 2005
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseasesLaetitia Cartier, Oliver Hartley, Michel Dubois-Dauphin, et al.
The Journal of Biological Chemistry|October 12, 2018
Rapid and low-cost multiplex synthesis of chemokine analogsMarianne Paolini-Bertrand, Fabrice Cerini, Elsa Martins, et al.
The Journal of Biological Chemistry|November 3, 2010
CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi networkJean-Michel Escola, Gabriel Kuenzi, Hubert Gaertner, et al.
Plos One|April 30, 2015
Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5Claudia Bönsch, Mihaela Munteanu, Irène Rossitto-Borlat, et al.
AIDS Research and Human Retroviruses|February 24, 2005
V3: HIV's switch-hitterOliver Hartley, Per Johan Klasse, Quentin J Sattentau, et al.
Vaccine|May 16, 2008
Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccinationKarim Dorgham, Valérie Abadie, Mutsunori Iga, et al.
Molecular Pharmacology|September 18, 2020
Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment BiasElsa Martins, Hellena Brodier, Irène Rossitto-Borlat, et al.
Pageof 9